Daewoong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Science Company Limited
sales of 776.22 billion Korean Won [US$693.16 million]
of which 77%
was Pharmaceutical Sales),
Dong-A Socio Holdings Co Ltd
(704.73 billion Korean Won [US$629.33 million]
of which 71%
was Pharmaceutication), and
Kwang Dong Pharmaceutical Company Limited
(955.45 billion Korean Won [US$853.22 million]
of which 43%
was Food Product Operations).
During the year ended December of 2015, sales at
Daewoong Pharmaceutical Company Limited were 839.69 billion Korean Won (US$749.84 million).
increase of 14.1%
versus 2014, when the company's sales were 735.89 billion Korean Won.
This was the third consecutive year of growth at Daewoong Pharmaceutical Company Limited.
Sales of Prevention Diseases saw an increase
20.5% in 2015, from
3.45 billion Korean Won to 4.16 billion Korean Won.